It’s easier than ever for doctors to prescribe a key medicine for opioid addiction since the U.S. government lifted an obstacle last year. But despite the looser restrictions and the ongoing overdose crisis, a new study finds little change in the number of people taking the medication.
Researchers analyzed prescriptions filled by U.S. pharmacies for the treatment drug buprenorphine. The number of prescribers rose last year after doctors no longer needed to get a special waiver to prescribe the drug, while the number of patients filling prescriptions barely budged.
It may take more than one year to see a bigger increase in patients, said study co-author Dr. Kao-Ping Chua of the University of Michigan Medical School.
“There are so many other barriers to prescribing that we have to address,” said Chua.
The findings were published Wednesday in the New England Journal of Medicine.
Trump Media fires auditing firm that US regulators have charged with 'massive fraud'
Guest Opinion: Xi's message to Americans
A 'lack of consequences' for managing personal information poorly
It's 20 years since the last ever episode of Friends. But from body
UK's medical regulator says sorry for striking off gay doctors before 1966
U.S. small yard, high fence strategy will eventually backfire
2 killed when a small plane headed to South Carolina crashes in Virginia, police say
U.S. politicians' national security paranoia intensifies